This medal recognizes Dr. Williamson's exemplary leadership of SCCT, as displayed throughout his nearly two decades of membership in the Society and particularly during his 10 years of service on the Board of Directors. SCCT is grateful for Dr. Williamson's many contributions as president (2021–2022) and his key role and influence on SCCT education — serving as faculty or giving talks more than 40 times in the past 8 years alone.

During his time serving in leadership roles on the SCCT Education and CME Committees, Dr. Williamson prioritized achieving and maintaining accreditation for the Society and has been instrumental in the continued high-quality delivery of SCCT’s Board Review Course, one of the cornerstones of the Society’s education. Above all, his leadership and vision for expanding and improving SCCT’s technologist education has been transformative for the Society and its technologist membership.

SCCT is honoring Dr. Dey for her extensive contributions to patient-specific risk prediction from quantitative CT and her research in automated AI-enabled derivation of imaging biomarkers from cardiac images, elucidating the relationships of coronary plaque and inflammation measured by cardiac CT and their changes with therapy, machine learning integration of novel imaging biomarkers, and AI-enabled cardiovascular CT for patient-specific prediction of adverse events.

Her development of AI software for characterizing coronary atherosclerotic plaque, quantification of aortic valve fibrocalcific thickening and automated measurement of epicardial adipose tissue has contributed to a variety of quantitative cardiac CT research projects that have forwarded the field. SCCT also honors her work as a committed mentor, supporting the work and careers of numerous MD and PhD imagers.

SSCCT has selected Dr. Blankstein for this award in recognition of his many contributions to the field of preventive cardiology, and for his dedication to improving patient outcomes through the use of cardiovascular CT. This award recognizes his profound impact on the field, like his key role in the 2021 Guideline for the Evaluation and Diagnosis of Chest Pain, which has significantly changed the landscape for cardiovascular CT and will lead to decreased CV-related mortality in the U.S. as it has in other countries. Dr. Blankstein is responsible for pioneering several initiatives that shape, educate and support the future of the field, including the SCCT Prevention Symposium, currently in its eighth year.

As president of SCCT, he launched the SCCT Future Leaders Program in 2019 to develop and strengthen the pipeline of committed early career cardiac CT imagers.

In addition, Ron has played a key role in improving patient access to cardiovascular CT by serving as the catalyst for what became a 7-year quest to achieve appropriate Medicare reimbursement, bringing in additional champions and regularly making himself available to educate stakeholders.